Search
for

    Glossary Monoclonal Antibodies

    laboratory-produced molecules that target specific cells or proteins

    Monoclonal antibodies (mAbs) are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance, or mimic the immune system's attack on cells. They are designed to bind to specific targets, such as proteins on the surface of cancer cells, making them useful in treating various diseases, including some types of cancer, autoimmune disorders, and infectious diseases.

    Related Terms

    Research 10 of 1000+

    1. Immunological characteristics and histological distribution of human hair fibrous proteins studied with anti-hair keratin monoclonal antibodies HKN-2, HKN-4, and HKN-6. Journal of Histochemistry & Cytochemistry · 1986 · 52 citations
    2. Generation of Pax1/PAX1-Specific Monoclonal Antibodies Monoclonal antibodies in immunodiagnosis and immunotherapy · 2016 · 10 citations
    3. Anti-keratin Monoclonal Antibodies for Identifying Animal Hair Fibers Textile Research Journal · 2004 · 8 citations
    4. Four murine monoclonal antibodies specific for the inner root sheath in the human hair follicle 1989 · 1 citations
    5. [Immunohistochemical study on the keratin expression in generating rat hair tissues using anti-hair keratin monoclonal antibodies]. PubMed · 1990
    6. [An immunohistochemical study on cell differentiation in the outer root sheath of the normal human anagen hair follicles with antikeratin monoclonal antibodies]. PubMed · 1990 · 6 citations
    7. Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study Journal of The American Academy of Dermatology · 2023
    8. Signs of some hematological diseases with the help of monoclonal antibodies LT-1, LT-2, LT-7 International journal of medicine and psychology. · 2024
    9. 468 Use of calcitonin gene-related peptide monoclonal antibodies in patients with rosacea: An exploratory, comparative case series Journal of Investigative Dermatology · 2023
    10. Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system Frontiers in Pharmacology · 2024 · 30 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →